scispace - formally typeset
J

Jan Plzak

Researcher at Charles University in Prague

Publications -  108
Citations -  2185

Jan Plzak is an academic researcher from Charles University in Prague. The author has contributed to research in topics: Head and neck squamous-cell carcinoma & Medicine. The author has an hindex of 22, co-authored 94 publications receiving 1754 citations. Previous affiliations of Jan Plzak include First Faculty of Medicine, Charles University in Prague.

Papers
More filters
Journal ArticleDOI

Galectin-3 - an emerging prognostic indicator in advanced head and neck carcinoma.

TL;DR: It is concluded that studies with an endogenous lectin as a marker are technically feasible and detection of accessible galectin-3-specific ligands is an independent prognostic marker in advanced head and neck squamous cell cancer with therapeutic potential.
Journal ArticleDOI

Smooth muscle actin-expressing stromal fibroblasts in head and neck squamous cell carcinoma: increased expression of galectin-1 and induction of poor prognosis factors.

TL;DR: In squamous cell carcinomas of head and neck, upregulation of galectin‐1 presence was highly significantly correlated to presence of smooth muscle actin‐positive cancer‐associated fibroblasts in the tumor (p = 4 × 10−8), and microarray analyses to the transcription profiles of the corresponding tumors provided new insights into the significance of presence of myofibroblast in squamouscell carcinoma.
Journal Article

Epidermal growth factor receptor--its expression and copy numbers of EGFR gene in patients with head and neck squamous cell carcinomas.

TL;DR: Criteria for cetuximab treatment in patients with HNSCC may differ from those already used for patients with colorectal carcinomas and should take different patterns of the EGFR protein overexpression into consideration.